Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Nov 08, 2022 4:19pm
RE:RE:The Lighter Side of Investing in ATE
easier to block ppl than get dunked on every day lmao
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Nov 08, 2022 4:06pm
Did you get the rest of your fill Davgro ?
She hit 48 at the end - did you get more ?
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 08, 2022 3:27pm
Your qouting truman????
now i know your confused.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 08, 2022 3:27pm
What do you call someone who believes everything they read?
Definitions of credulous. adjective. showing a lack of judgment or experience. “so credulous he believes everything he reads” Synonyms: naif, naive. dav, davgro
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 08, 2022 3:22pm
RE:The Lighter Side of Investing in ATE
We are on a well deserved path with 346 - waiting game now. Just enjoy the ride while others haven't a clue. We should learn more about the IBD path shortly. Here's an interesting
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 08, 2022 3:13pm
Davgro is in full panic mode
he seems very confused, i think he is almost ready for the nut house hahaha, he has not fooled anyone with this log in log out stuff it is total B.S. he reads every post on this board. he is down
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Nov 08, 2022 1:30pm
The Lighter Side of Investing in ATE
"If you can't convince them, confuse them" - Harry S. Truman Just for entertainment value I once a week transport myself into the ATE Iggy Netherworld. It’s very easy to do, just
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Nov 08, 2022 10:45am
I withdrew
my 49 cent order. and replaced it with a 47 cent order for 3k shares, geting in slowly this is a high risk stock and i rate management credibility very low.
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 08, 2022 9:35am
RE:RE:Cheap ATE Shares
Then again - I don't have an order in - just playing the market. Hope you can get your fill Davgro - this is the time ... if you're going to get it !!!
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Nov 08, 2022 12:06am
RE:RE:Cheap ATE Shares
i had a 49 cent order that also never got filed. my guess he never got filed because he never had a order, he is a liar but that is what a panicked underwater share holder does. see it all the
...more
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 07, 2022 10:50pm
I also find it funny
cannacord is selling shares at .50. Did they not give ate a price target of 7.00 a couple years ago?
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 07, 2022 10:46pm
???
???
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Nov 07, 2022 10:45pm
Id save some coppers for when it hits .30's
as long as money dwindles away, the Share price will follow. Ww3 eminent
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Nov 07, 2022 3:35pm
RE:Cheap ATE Shares
Congrats ... Not sure how you did that ... I couldn't even get it at 50 or 51.
(450)
•••
davgro
X
View Profile
View Bullboard History
Post by
davgro
on Nov 07, 2022 3:15pm
Cheap ATE Shares
Got a partial fill of my 20000 share ATE stink bid at C$0.48. Must have been a "weak hands" market sell order as the bid is back up to C$0.50. Thanks for the cheap shares. :)
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >